Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: BJU Int. 2009 Nov 3;105(9):1222–1225. doi: 10.1111/j.1464-410X.2009.09007.x

TABLE 2.

Multivariate models for the association between statins and positive surgical margins, tumour volume and percentage cancer at RP, adjusting for clinical stage and grade

Variables Coefficient (SE) P
Positive surgical margins
 Statin use −0.35 (0.16) 0.034
 Clinical stage ≥T2 0.23 (0.17) 0.162
 Biopsy Gleason score 7–10 1.12 (0.15) <0.001
Tumour volume
 Statin use −0.66 (0.36) 0.061
 Clinical stage ≥T2 0.66 (0.40) 0.098
 Biopsy Gleason score 7–10 3.63 (0.38) <0.001
% cancer at RP
 Statin use −1.13 (0.66) 0.088
 Clinical stage ≥T2 2.00 (0.74) 0.007
 Biopsy Gleason score 7–10 7.36 (0.70) <0.001